A randomized control trial measuring the effectiveness of a mouth-exercising device for mucosal burning in oral submucous fibrosis
- PMID: 27720659
- DOI: 10.1016/j.oooo.2016.07.026
A randomized control trial measuring the effectiveness of a mouth-exercising device for mucosal burning in oral submucous fibrosis
Abstract
Objectives: To evaluate effect of ice-cream stick exercise regimen with or without a mouth-exercising device (MED) on mucosal burning sensation in oral submucous fibrosis.
Study design: In total, 282 patients with oral submucous fibrosis were treated with topical corticosteroid and oral antioxidant and the ice-cream stick exercise regimen. Patients in subgroups A1, A2, and A3 were additionally given a new MED. Patients in subgroups A1 and B1 patients with interincisal distance (IID) of 20 to 35 mm were managed without any additional therapy; patients in subgroups A2 and B2 with IID of 20 to 35 mm were additionally managed with intralesional injections; and those in subgroups A3 and B3 with IID less than 20 mm were managed surgically. Subjective evaluation of decrease in the oral mucosal burning was measured on a visual analogue scale (VAS). Analysis of variance and Tukey's multiple post hoc analysis were carried out to present the results.
Results: Patients using the MED, that is, subgroups A1, A2, and A3, showed reduction in burning sensation in the range of 64.8% to 71.1% and 27.8% to 30.9%, whereas in subgroups B1, B2, and B3, reduction in burning sensation ranged from 64.7% to 69.9% and from 29.3% to 38.6% after 6 months. The wo-way analysis of variance indicated statistically significant results in changes in initial VAS scores to 6-monthly VAS scores between MED users and non-MED users.
Conclusions: The MED helps to enhance the rate of reduction of mucosal burning sensation, in addition to the conventional ice-cream stick regimen, as an adjunct to local and surgical treatment.
Copyright © 2016 Elsevier Inc. All rights reserved.
Comment in
-
A randomized control trial measuring the effectiveness of a mouth-exercising device for mucosal burning in oral submucous fibrosis: a commentary.Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Jun;123(6):735. doi: 10.1016/j.oooo.2017.01.016. Epub 2017 Feb 21. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017. PMID: 28396073 No abstract available.
-
Reply to: Details of the participants and medical intervention used in the study evaluating the effect of a mouth exercising device on burning sensation in oral submucous fibrosis.Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Jun;123(6):735-737. doi: 10.1016/j.oooo.2017.01.017. Epub 2017 Feb 21. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017. PMID: 28412237 No abstract available.
Similar articles
-
Clinical efficacy of mouth exercising devices in oral submucous fibrosis: A systematic review.J Oral Biol Craniofac Res. 2020 Oct-Dec;10(4):315-320. doi: 10.1016/j.jobcr.2020.06.010. Epub 2020 Jul 3. J Oral Biol Craniofac Res. 2020. PMID: 32714782 Free PMC article. Review.
-
Clinical Efficacy of a Mouth-Exercising Device Adjunct to Local Ointment Intra-Lesional Injections and Surgical Treatment for Oral Submucous Fibrosis: a Randomized Controlled Trial.Asian Pac J Cancer Prev. 2016;17(3):1255-9. doi: 10.7314/apjcp.2016.17.3.1255. Asian Pac J Cancer Prev. 2016. PMID: 27039756 Clinical Trial.
-
Efficacy of spirulina as an antioxidant adjuvant to corticosteroid injection in management of oral submucous fibrosis.Indian J Dent Res. 2013 May-Jun;24(3):347-50. doi: 10.4103/0970-9290.118001. Indian J Dent Res. 2013. PMID: 24025883
-
Novel mouth-exercising device for oral submucous fibrosis.J Prosthodont. 2012 Oct;21(7):556-60. doi: 10.1111/j.1532-849X.2012.00874.x. Epub 2012 Jul 10. J Prosthodont. 2012. PMID: 22779909
-
Review of drug treatment of oral submucous fibrosis.Oral Oncol. 2012 May;48(5):393-8. doi: 10.1016/j.oraloncology.2011.11.021. Epub 2011 Dec 27. Oral Oncol. 2012. PMID: 22206808 Review.
Cited by
-
Evaluating the Oral-Health-Related Quality of Life of Oral Submucous Fibrosis Patients before and after Treatment Using the OHIP-14 Tool.Int J Environ Res Public Health. 2022 Feb 5;19(3):1821. doi: 10.3390/ijerph19031821. Int J Environ Res Public Health. 2022. PMID: 35162842 Free PMC article. Clinical Trial.
-
Mechanistic Investigation of Curcuma Protection against Oral Submucous Fibrosis.Evid Based Complement Alternat Med. 2022 Aug 9;2022:3891598. doi: 10.1155/2022/3891598. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35982996 Free PMC article.
-
Interventions for managing oral submucous fibrosis.Cochrane Database Syst Rev. 2024 Feb 28;2(2):CD007156. doi: 10.1002/14651858.CD007156.pub3. Cochrane Database Syst Rev. 2024. PMID: 38415846 Free PMC article.
-
Clinical efficacy of mouth exercising devices in oral submucous fibrosis: A systematic review.J Oral Biol Craniofac Res. 2020 Oct-Dec;10(4):315-320. doi: 10.1016/j.jobcr.2020.06.010. Epub 2020 Jul 3. J Oral Biol Craniofac Res. 2020. PMID: 32714782 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources